Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies

Cancer immunotherapy especially immune checkpoint inhibition has achieved unprecedented successes in cancer treatment. However, there are many patients who failed to benefit from these therapies, highlighting the need for new combinations to increase the clinical efficacy of immune checkpoint inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Miaoqin, Hu, Shiman, Li, Yiling, Jiang, Ting Ting, Jin, Hongchuan, Feng, Lifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677403/
https://www.ncbi.nlm.nih.gov/pubmed/33214545
http://dx.doi.org/10.1038/s41392-020-00347-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677403/
https://www.ncbi.nlm.nih.gov/pubmed/33214545
http://dx.doi.org/10.1038/s41392-020-00347-9

Ejemplares similares